Scientists have engineered an antibody that attacks 99% of HIV strains and can prevent infection in primates, a collaboration between the US National Institutes of Health and pharmaceutical company Sanofi.

See the source article by following the link below:
Scientists have engineered an antibody that attacks 99% of HIV strains and can prevent infection in primates, a collaboration between the US National Institutes of Health and pharmaceutical company Sanofi.